Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2012 When the Physician's Medical Judgment is Rejected, Commentary 2 Robert E. Cranston, MD Physicians must maintain a delicate balance between patient autonomy and preventing harm when faced with patients who refuse treatment. Virtual Mentor. 2012;6(2):82-85. doi: 10.1001/virtualmentor.2004.6.2.ccas2-0402. Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 2 Kevin O'Rourke, OP Physicians have an ethical obligation to admit mistakes to their patients, even if no harm came of the mistakes. Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403. In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408. Pagination First page « First Previous page ‹ Previous … Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Next page Next › Last page Last »
Case and Commentary Feb 2012 When the Physician's Medical Judgment is Rejected, Commentary 2 Robert E. Cranston, MD Physicians must maintain a delicate balance between patient autonomy and preventing harm when faced with patients who refuse treatment. Virtual Mentor. 2012;6(2):82-85. doi: 10.1001/virtualmentor.2004.6.2.ccas2-0402.
Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 2 Kevin O'Rourke, OP Physicians have an ethical obligation to admit mistakes to their patients, even if no harm came of the mistakes. Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403.
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408.